MILLA, MONICA
MILLA, MONICA
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab.
2013 Matucci A; Pratesi S; Petroni G; Nencini F; Virgili G; Milla M; Maggi E; Vultaggio A.
Applicability of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to ulcerative colitis: a preliminary study
2024 Innocenti, Tommaso; Rocco, Carmen; Lynch, Erica Nicola; Milla, Monica; Galli, Andrea; Dragoni, Gabriele
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions
2016 Vultaggio A.; Petroni G.; Pratesi S.; Nencini F.; Cammelli D.; Milla M.; Prignano F.; Annese V.; Romagnani S.; Maggi E.; Matucci A.
Clinical characteristics of psoriasis in inflammatory bowel disease patients
2017 Pescitelli L.; Gianotta M.; Ricceri F.; Lazzeri L.; Milla M.; Prignano F.
Correlation of Ultrasound Scores with Endoscopic Activity in Crohn's Disease: A Prospective Exploratory Study
2023 Dragoni, Gabriele; Gottin, Matteo; Innocenti, Tommaso; Lynch, Erica Nicola; Bagnoli, Siro; Macrì, Giuseppe; Bonanomi, Andrea Giovanni; Orlandini, Beatrice; Rogai, Francesca; Milani, Stefano; Galli, Andrea; Milla, Monica; Biagini, Maria Rosa
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry
2022 Tapete G, Bertani L, Pieraccini A, Lynch EN, Giannotta M, Morganti R, Biviano I, Naldini S, Mumolo MG, De Nigris F, Calella F, Bagnoli S, Minciotti M, Maltinti S, Rentini S, Ceccarelli L, Lionetti P, Milla M, Costa F.
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease
2020 Roselli, Jenny; Innocenti, Tommaso; Lynch, Erica Nicola; Parisio, Laura; Macrì, Giuseppe; Milla, Monica; Mello, Tommaso; Galli, Andrea; Milani, Stefano; Tarocchi, Mirko
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease
2021 Innocenti, Tommaso; Roselli, Jenny; Lynch, Erica N; Apolito, Pasquale; Parisio, Laura; Bagnoli, Siro; Macrì, Giuseppe; Rogai, Francesca; Tarocchi, Mirko; Milani, Stefano; Galli, Andrea; Milla, Monica; Dragoni, Gabriele
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study
2021 Grazie, Marco Le; Bagnoli, Siro; Dragoni, Gabriele; Caini, Saverio; Annese, Vito; Innocenti, Tommaso; Deiana, Simona; Manetti, Natalia; Milani, Stefano; Galli, Andrea; Milla, Monica
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey
2022 Innocenti, Tommaso; Roselli, Jenny; Taylor, Alice; Dragoni, Gabriele; Lynch, Erica Nicola; Campani, Claudia; Gottin, Matteo; Bagnoli, Siro; Macrì, Giuseppe; Rogai, Francesca; Milani, Stefano; Galli, Andrea; Milla, Monica
Stevens-Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease
2020 Roselli, Jenny; Innocenti, Tommaso; Lynch, Erica Nicola; Parisio, Laura; Apolito, Pasquale; Mello, Tommaso; Macrì, Giuseppe; Milla, Monica; Biagini, Maria Rosa; Tarocchi, Mirko; Milani, Stefano; Galli, Andrea
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders
2018 Nencini F.; Vultaggio A.; Pratesi S.; Cammelli D.; Milla M.; Fiori G.; Bagnoli S.; Prignano F.; Romagnani S.; Maggi E.; Matucci A.
Thrombosis in inflammatory bowel diseases: What's the link?
2015 Giannotta, Martina*; Tapete, Gherardo; Emmi, Giacomo; Silvestri, Elena; Milla, Monica
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. | 2013 | Matucci A; Pratesi S; Petroni G; Nencini F; Virgili G; Milla M; Maggi E; Vultaggio A. | |
| Applicability of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to ulcerative colitis: a preliminary study | 2024 | Innocenti, Tommaso; Rocco, Carmen; Lynch, Erica Nicola; Milla, Monica; Galli, Andrea; Dragoni, Gabriele | |
| Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions | 2016 | Vultaggio A.; Petroni G.; Pratesi S.; Nencini F.; Cammelli D.; Milla M.; Prignano F.; Annese V.; Romagnani S.; Maggi E.; Matucci A. | |
| Clinical characteristics of psoriasis in inflammatory bowel disease patients | 2017 | Pescitelli L.; Gianotta M.; Ricceri F.; Lazzeri L.; Milla M.; Prignano F. | |
| Correlation of Ultrasound Scores with Endoscopic Activity in Crohn's Disease: A Prospective Exploratory Study | 2023 | Dragoni, Gabriele; Gottin, Matteo; Innocenti, Tommaso; Lynch, Erica Nicola; Bagnoli, Siro; Macrì, Giuseppe; Bonanomi, Andrea Giovanni; Orlandini, Beatrice; Rogai, Francesca; Milani, Stefano; Galli, Andrea; Milla, Monica; Biagini, Maria Rosa | |
| Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry | 2022 | Tapete G, Bertani L, Pieraccini A, Lynch EN, Giannotta M, Morganti R, Biviano I, Naldini S, Mumolo MG, De Nigris F, Calella F, Bagnoli S, Minciotti M, Maltinti S, Rentini S, Ceccarelli L, Lionetti P, Milla M, Costa F. | |
| Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease | 2020 | Roselli, Jenny; Innocenti, Tommaso; Lynch, Erica Nicola; Parisio, Laura; Macrì, Giuseppe; Milla, Monica; Mello, Tommaso; Galli, Andrea; Milani, Stefano; Tarocchi, Mirko | |
| Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease | 2021 | Innocenti, Tommaso; Roselli, Jenny; Lynch, Erica N; Apolito, Pasquale; Parisio, Laura; Bagnoli, Siro; Macrì, Giuseppe; Rogai, Francesca; Tarocchi, Mirko; Milani, Stefano; Galli, Andrea; Milla, Monica; Dragoni, Gabriele | |
| Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study | 2021 | Grazie, Marco Le; Bagnoli, Siro; Dragoni, Gabriele; Caini, Saverio; Annese, Vito; Innocenti, Tommaso; Deiana, Simona; Manetti, Natalia; Milani, Stefano; Galli, Andrea; Milla, Monica | |
| Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey | 2022 | Innocenti, Tommaso; Roselli, Jenny; Taylor, Alice; Dragoni, Gabriele; Lynch, Erica Nicola; Campani, Claudia; Gottin, Matteo; Bagnoli, Siro; Macrì, Giuseppe; Rogai, Francesca; Milani, Stefano; Galli, Andrea; Milla, Monica | |
| Stevens-Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease | 2020 | Roselli, Jenny; Innocenti, Tommaso; Lynch, Erica Nicola; Parisio, Laura; Apolito, Pasquale; Mello, Tommaso; Macrì, Giuseppe; Milla, Monica; Biagini, Maria Rosa; Tarocchi, Mirko; Milani, Stefano; Galli, Andrea | |
| The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders | 2018 | Nencini F.; Vultaggio A.; Pratesi S.; Cammelli D.; Milla M.; Fiori G.; Bagnoli S.; Prignano F.; Romagnani S.; Maggi E.; Matucci A. | |
| Thrombosis in inflammatory bowel diseases: What's the link? | 2015 | Giannotta, Martina*; Tapete, Gherardo; Emmi, Giacomo; Silvestri, Elena; Milla, Monica |